-
Vaccines, Blood & Biologics
-
Anticoagulant Sodium Citrate 4% w/v Solution, USP
| Product name: Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P. Manufacturer: Haemonetics Corporation, Braintree, MA Indication for Use: Only with automated apheresis devices in the collection of human plasma or in performing therapeutic plasma exchange procedures Approval Date: 3/3/2000 Type of submission: New Drug Application |
-
- Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P. - Approval Letter
- Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P. - Approval Letter (PDF - 71KB)
- Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P. - Summary Basis of Approval
- Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P. - Summary Basis of Approval (PDF - 119KB)
-
Contact Us
Consumer Affairs Branch (CBER)
- (800) 835-4709
- (301) 827-1800
- ocod@fda.hhs.gov
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-
-